Multivariate analysis of independent roles of socioeconomic status, occupational physical activity, reproductive factors, and postmenopausal hormonal therapy in risk of breast cancer.


Journal

Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 03 11 2021
accepted: 12 03 2022
pubmed: 3 4 2022
medline: 14 5 2022
entrez: 2 4 2022
Statut: ppublish

Résumé

This case-control study assesses the independent roles of reproductive history, postmenopausal hormonal therapy (HT), socioeconomic status (SES), and occupational physical activity on the risk of breast cancer (BC). Odds ratios (OR) were estimated from conditional logistic multivariate regression model in a data set of 19,253 Finnish women diagnosed with BC between 1994 and 2013 and 96,265 age-matched population controls. Both pre- and postmenopausal white-collar workers had significantly increased risk of ductal and lobular BC as compared to manual workers. Moderate occupational physical activity reduced risk of lobular BC by 14%. There was a transient increase in the risk of BC observed after each birth followed by a protective effect starting some years after the delivery. As the number of children increased, the short-term excess risk was lower and protective effect was observed earlier. Continuous estrogen-progestin therapy (EPT) significantly increased the risk of both ductal and lobular BC and the magnitude of risk was directly proportional to duration of use (OR for 5+ years of use 2.26, 95% confidence interval 2.12-2.42). Monthly EPT for 5+ years increased the risk (OR 1.32, 95% CI 1.20-1.45). Users of estradiol plus levonorgestrel intrauterine system devices showed ORs of 1.56 (95% CI 1.45-1.69) and 2.18 (95% CI 1.81-2.64) for ductal and lobular BC, respectively. This study concludes that pregnancy has a dual effect on BC risk, with a transient increase in risk followed by a long-term protective effect. The SES and HT have a large effect on BC risk while occupational physical activity has only a small independent effect.

Identifiants

pubmed: 35366162
doi: 10.1007/s10549-022-06571-x
pii: 10.1007/s10549-022-06571-x
pmc: PMC9090885
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

495-505

Subventions

Organisme : Tampereen Yliopisto
ID : Employee

Informations de copyright

© 2022. The Author(s).

Références

J Nutr. 2002 Nov;132(11 Suppl):3456S-3464S
pubmed: 12421870
Cancer Med. 2020 Jan;9(1):385-393
pubmed: 31724329
Am J Epidemiol. 2008 Jan 15;167(2):230-9
pubmed: 17965112
Br J Cancer. 2009 Feb 10;100(3):538-44
pubmed: 19190634
Int J Cancer. 2011 Jan 1;128(1):144-56
pubmed: 20232395
Exerc Sport Sci Rev. 2006 Oct;34(4):182-93
pubmed: 17031257
BMC Cancer. 2019 Mar 4;19(1):199
pubmed: 30832620
Int J Cancer. 1999 Mar 31;81(1):56-61
pubmed: 10077153
Cancer Causes Control. 2013 Jun;24(6):1257-62
pubmed: 23526070
Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):593-600
pubmed: 12101105
Br J Cancer. 2003 Sep 1;89(5):847-51
pubmed: 12942116
Lancet. 2019 Sep 28;394(10204):1159-1168
pubmed: 31474332
Value Health. 2019 Jan;22(1):104-128
pubmed: 30661625
Eur J Epidemiol. 2000;16(10):973-80
pubmed: 11338130
Cancer Causes Control. 2002 May;13(4):299-305
pubmed: 12074499
Eur J Cancer. 1994;30A(7):969-73
pubmed: 7946593
Lancet. 2003 Aug 9;362(9382):419-27
pubmed: 12927427
Acta Oncol. 2017 Jan;56(1):75-80
pubmed: 27919198
Breast Cancer Res Treat. 1996;38(3):305-11
pubmed: 8739084
Eur J Public Health. 2016 Oct;26(5):804-813
pubmed: 27221607
Am J Epidemiol. 2007 Mar 1;165(5):524-9
pubmed: 17132697
Br J Cancer. 2005 Jan 17;92(1):167-75
pubmed: 15597097
Int J Cancer. 2016 Feb 1;138(3):584-93
pubmed: 26289549
Epidemiology. 2007 Jan;18(1):137-57
pubmed: 17130685
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Int J Cancer. 2004 Sep 1;111(3):451-6
pubmed: 15221976
Breast Cancer Res Treat. 2002 Mar;72(2):107-15
pubmed: 12038701
Cancer Treat Res. 1988;40:119-65
pubmed: 2908648
Breast Cancer Res. 2006;8(4):R43
pubmed: 16859501
Br Med J. 1980 Aug 9;281(6237):419-21
pubmed: 7427299
Acta Oncol. 2016;55(2):188-92
pubmed: 26243443
Int J Cancer. 2003 Jul 10;105(5):692-700
pubmed: 12740920
Int J Cancer. 2016 May 15;138(10):2346-56
pubmed: 26684063
Obstet Gynecol. 2006 Dec;108(6):1354-60
pubmed: 17138766
Cancer. 2011 May 1;117(9):1946-56
pubmed: 21509772
Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):361-8
pubmed: 11927496
Cancer Causes Control. 2018 Nov;29(11):1027-1038
pubmed: 30151565
J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):89-96
pubmed: 17113977
Acta Oncol. 2009;48(5):791-800
pubmed: 19225948
Acta Oncol. 1994;33(4):365-9
pubmed: 8018367
Int J Cancer. 2003 Nov 1;107(2):268-70
pubmed: 12949805
Cancer. 2003 Mar 15;97(6):1387-92
pubmed: 12627501
Am J Epidemiol. 2013 Aug 1;178(3):359-71
pubmed: 23899816
Cancer Causes Control. 1999 Oct;10(5):423-30
pubmed: 10530613
Obstet Gynecol. 2014 Aug;124(2 Pt 1):292-299
pubmed: 25004338
Soc Sci Med. 1987;24(7):601-6
pubmed: 3589754
Int J Equity Health. 2017 Oct 16;16(1):182
pubmed: 29037209
Toxicol Pathol. 2010 Jan;38(1):110-22
pubmed: 19933552
Methods Mol Biol. 2011;675:127-64
pubmed: 20949386
Epidemiol Rev. 1993;15(1):17-35
pubmed: 8405201
Acta Oncol. 2018 Apr;57(4):440-455
pubmed: 29226751
Br J Sports Med. 2008 Aug;42(8):636-47
pubmed: 18487249
Br J Cancer. 2001 Sep 28;85(7):962-5
pubmed: 11592766
Cancer Causes Control. 2002 Nov;13(9):831-8
pubmed: 12462548
J Clin Endocrinol Metab. 2001 Jan;86(1):16-23
pubmed: 11231971
BMC Public Health. 2012 Oct 31;12:936
pubmed: 23113905
Cancer Epidemiol. 2011 Oct;35(5):438-41
pubmed: 21227766
Breast Cancer Res Treat. 2014 Jun;145(2):481-9
pubmed: 24748570
Ann Epidemiol. 2015 Sep;25(9):687-97
pubmed: 26099193
Eur J Contracept Reprod Health Care. 2001 Jan;6 Suppl 1:23-6
pubmed: 11336430
Recent Results Cancer Res. 2011;186:13-42
pubmed: 21113759
Cancer Causes Control. 2015 Dec;26(12):1779-89
pubmed: 26450605
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1643-54
pubmed: 20501751
Acta Obstet Gynecol Scand. 2020 Aug;99(8):970-982
pubmed: 31990981
Horm Behav. 2012 Aug;62(3):263-71
pubmed: 22406114
Am J Pathol. 1979 Sep;96(3):721-36
pubmed: 112872
Nature. 1983 Jun 30;303(5920):767-70
pubmed: 6866078
JAMA. 2003 Jun 25;289(24):3254-63
pubmed: 12824206
Br J Cancer. 2020 Mar;122(5):726-732
pubmed: 31919405
Int J Cancer. 2010 Jan 15;126(2):483-9
pubmed: 19588504
Ann Oncol. 2018 Aug 1;29(8):1771-1776
pubmed: 29917061
Obstet Gynecol. 2014 Apr;123(4):811-6
pubmed: 24785609
J Intern Med. 2018 May;283(5):430-445
pubmed: 29476569
Br J Cancer. 2005 Aug 8;93(3):364-71
pubmed: 16079783
Breast Cancer Res. 2013;15(4):R62
pubmed: 23938070

Auteurs

Sushmita Katuwal (S)

Faculty of Social Sciences, Tampere University, Arvo Ylpön katu 34, 33520, Tampere, Finland. sushmita.katuwal@tuni.fi.

Juha Tapanainen (J)

Department of Obstetrics and Gynecology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
Department of Obstetrics and Gynecology, PEDEGO Research Unit, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.

Eero Pukkala (E)

Faculty of Social Sciences, Tampere University, Arvo Ylpön katu 34, 33520, Tampere, Finland.
Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH